Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Syllabus for Dermatology Nursing
Dermoscopy Observership Syllabus IADVL
Opportunities for Residents through the Indian Association of Dermatologists, Venereologists and Leprologists
IADVL Academy position statement on monkeypox
Dermatosurgery Practice and Implications of COVID19 Pandemic Recommendations by IADVL SIG Dermatosurgery
Dermoscopy Practice during COVID19 Pandemic Recommendations by SIG Dermoscopy
Hand Hygiene Practices and Risk and Prevention of Hand Eczema during the COVID19 Pandemic
IADVL Position Statement and Recommendations on Post Lockdown Dermatology Practice Amidst the Covid 19 Pandemic
IADVL position statement on current COVID 19 virus pandemic
IADVL Revised position statement for practice of dermatology by our members
IADVL undergraduate logbook
Impact of COVID 19 Pandemic on Dermatologists and Dermatology Practice
Lasers Use in Dermatology Practice in the Evolving COVID19 Scenario Recommendations by SIG Lasers
Management of Leprosy in the Context of COVID19 Pandemic Recommendations by SIG Leprosy
Platelet-Rich Fibrin Preparation and Use in Dermatology
Platelet-Rich Plasma in Aesthetics
Platelet-Rich Plasma in Androgenetic Alopecia
Preparation of Platelet-Rich Plasma National IADVL PRP Taskforce Recommendations
Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive: Immunomodulatory Therapy
Recommendations for Management of Childhood Psoriasis
Recommendations for Pediatric Dermatology Practice during COVID 19 Pandemic
Reflections on research
Safer Practice of Aesthetic Dermatology during the COVID‐19 Pandemic- Recommendations by SIG Aesthetics (IADVL Academy)
Teledermatology consultation form
Teledermatology Practice the need of the hour
Teledermatology teleconsultation consent form
Telemedicine practice guidelines (May 2020)
Updates on Management of Leprosy in the Context of COVID19 Pandemic Recommendations by IADVL SIG Leprosy
Use of Immunosuppressants : Immunomodulators in Autoimmune: Inflammatory Dermatologic Diseases during COVID19 PandemicGeneral Recommendation Based on Available Evidence